Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever
- 1 June 1989
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (6), 987-988
- https://doi.org/10.1128/aac.33.6.987
Abstract
A study of 43 patients with Mediterranean spotted fever showed that a 2-day course of ciprofloxacin or a 2-day course of doxycycline may be an effective mode of therapy. All patients in both arms of the study were cured; however, doxycycline produced a more rapid defervescence.This publication has 11 references indexed in Scilit:
- Ciprofloxacin: In Vitro, Experimental, and Clinical EvaluationClinical Infectious Diseases, 1988
- Comparative, Randomized Trial of One-Day Doxycycline Versus 10-Day Tetracycline Therapy for Mediterranean Spotted FeverThe Journal of Infectious Diseases, 1987
- Ciprofloxacin therapy for Mediterranean spotted feverAntimicrobial Agents and Chemotherapy, 1986
- In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assayAntimicrobial Agents and Chemotherapy, 1986
- Mediterranean Spotted Fever in an American WomanArchives of Internal Medicine, 1985
- Mediterranean Spotted Fever: A Cooperative Study of 227 CasesClinical Infectious Diseases, 1985
- AUTOCHTHONIC MEDITERRANEAN SPOTTED FEVER IN WEST GERMANYThe Lancet, 1984
- MEDITERRANEAN SPOTTED FEVER IN BELGIUMThe Lancet, 1984
- [Malignant form of Mediterranean boutonneuse fever. 6 cases].1983
- Serological diagnosis of Mediterranean spotted fever.1979